MedPath

Comparison of marma therapy and Hridya amrit vati in high blood pressure

Not Applicable
Conditions
Health Condition 1: I10- Essential (primary) hypertension
Registration Number
CTRI/2020/05/025316
Lead Sponsor
ttarakhand ayurved University Rishikul campus haridwar
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Subjects will be enrolled with stage 1 hypertension (130-139/80-89)

Hypertensive patients who are drug-naive will be enrolled for the study

Normal LV function

Exclusion Criteria

Hypertensive patients with B.P greater or equal to 140 / 90 mmHg

LVEF < 50 %

CKD , Serum creatinine > 1.7

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
lowering in B.P from 140/90 mmhg to the normal ( Acc to the ACC and AHA )Timepoint: 6 months
Secondary Outcome Measures
NameTimeMethod
not anyTimepoint: not any
© Copyright 2025. All Rights Reserved by MedPath